Cancer as an ethical challenge.- Historical aspects of the
„fight against cancer.- One in four dies of cancer.” Questions
about the epidemiology of malignant tumors.- Ethical issues related
to human papillomavirus vaccination programs: an example from
Bangladesh.- Ethical challenges around cell lines in cancer
research.- Risk-adapted prevention. Governance perspective for
benefits of genetic (breast cancer) risk.- The right to know and
not to know: predictive genetic diagnosis and non-diagnosis.-
Benefits and harms of cancer screening.- Ethical dilemmas in
conducting clinical trials.- Ethical aspects in cancer drug
approval, balancing individual versus societal perspectives.- Liver
living donation for cancer patients: benefits, risks,
justification.- Quality assurance of cancer medication and the
challenge of biosimilars.- Cancer in children.- Pain and palliative
medicine.- Advance directives for medical decisions.- Euthanasia
and assisted suicide.- Doctor's health and the health
ofcaregivers.- Diagnosis breast cancer. An ethnographic study of
illness and disease.- The patient’s view.- The patients‘ advocate.-
Cancer in literature.
Axel W. Bauer studied medicine at Freiburg University and
graduated in 1980. In 1986, he completed his “habilitation”
(postdoctoral studies) in the field of History of Medicine at
Heidelberg University. Since 2004, he has been Professor of
History, Philosophy and Ethics in Medicine and Head of this
Speciality at the Medical Faculty Mannheim, Heidelberg University.
From 2008 to 2012, he was a member of the German Ethics Council in
Berlin. Since 2019, he has been a member of the European Academy of
Sciences and Arts in Salzburg. His main areas of research are the
history of pathology and pathological anatomy, institutionalization
of medical disciplines, development of scientific medicine, medical
ethics and bioethics. He has published more than 500 original
papers and 20 books on these subjects.
Ralf-Dieter Hofheinz studied medicine at Heidelberg
University and at theUniversity of La Plata, Argentina. He
graduated in 1998 and trained in Internal Medicine andMedical
Oncology at the University Medical Centre Mannheim, Heidelberg
University. Since 2010, he has been Head of the Oncological
Outpatient Department at the University Hospital Mannheim. A member
of the steering committee of the AIO of the German cancer society,
from 2012 to 2018, Hofheinz served as a national representative for
Germany at the European Society of Medical Oncology (ESMO). His
main fields of research are multimodality treatment of
gastrointestinal tumors, new drug development, quality of life and
PRO research, and medical history. He is a reviewer for several
medical journals, including The Lancet Oncology and Journal of
Clinical Oncology. Hofheinz has published more than 200 original
papers, 50 book chapters and 4 books.
Jochen Sven Utikal studied medicine at Ulm University and graduated in 2001. After his residency in Dermatology at Ulm University and at the University Medical Centre Mannheim, Heidelberg University, he was Scientist and Research Associate at the Harvard Stem Cell Institute and the Massachusetts General Hospital Cancer Center. Since 2012, he has been Head of the Skin Cancer Unit at the German Cancer Research Center (DKFZ) and the University Medical Centre Mannheim. His main fields of research are translational melanoma research, stem cell features of tumor cells and target discoveries in the field of melanoma. He is a reviewer for several medical journals and has published more than 240 papers in peer-reviewed international scientific journals, as well as 13 book chapters.
“Primarily oriented toward a medically sophisticated audience including physicians, nurses, and other healthcare providers. … it has implications for all who have an interest in cancer and cancer patients.” (Gregory A Otterson, Doody's Book Reviews, December 17, 2021)
 |
Ask a Question About this Product More... |
|
